Stay updated on Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.

Latest updates to the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page
- Check6 days agoChange DetectedThe page now displays details for the completed pegcetacoplan study in patients with transplant-associated thrombotic microangiopathy after stem cell transplantation, including its eligibility criteria, study plan, outcome measures, participating locations, and study documents.SummaryDifference67%

- Check12 days agoChange DetectedThe footer now identifies ClinicalTrials.gov as revision v3.8.0 rather than v3.7.2; the study record remains inaccessible on the displayed error page.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the 403 error page for the study record.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision marker changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on a 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. The header and footer remain, but the main study details, documents, and related sections are no longer accessible.SummaryDifference20%

Stay in the know with updates to Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.